Showing results (21-30 of 52) with videos related to
Sort By:
Pageof 6
Genes, Chromosomes & Cancer|October 28, 1998
Mapping of a new target region of allelic loss to a 6-cM interval at 21q21 in primary breast cancersK Ohgaki, A Iida, F Kasumi, et al.Hinyokika Kiyo. Acta Urologica Japonica|May 20, 1998
[Adrenal pheochromocytoma associated with renal cell carcinoma: report of two cases]K Ohgaki, Y Kondo, G Kimura, et al.Anticancer Research|March 1, 1989
In vivo inhibitory effect of a conjugate of immunoglobulin G and melphalan, K18, on human tumors transplanted in nude miceS Imai, Y Nio, T Shiraishi, et al.Nihon Geka Hokan. Archiv Fur Japanische Chirurgie|March 1, 1992
[A case report of serous cystadenoma located in pancreatic tail]J Kaganoi, T Hori, T Nagai, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1988
[Immunotherapy of gastric cancer]N Kan, K Ohgaki, T Okino, et al.Nihon Geka Gakkai Zasshi|March 1, 1986
[Augmentation of the anti-tumor activity of regional lymph node lymphocytes and spleen cells of tumor-bearing mice by culture with T cell growth factor in vitro--a comparison of the intestinal cancer model and footpad cancer model]T Hori, N Kan, T Inamoto, et al.Human Cell|September 1, 1992
[Augmentation of therapeutic effect of adoptive immunotherapy through a synergy between transferred killer cells and host's fresh lymphocytes]N Kan, S Yamasaki, T Harada, et al.Journal of Human Genetics|July 14, 2001
Definition of a 1-Mb homozygous deletion at 9q32-q33 in a human bladder-cancer cell lineH Fujiwara, M Emi, H Nagai, et al.Nihon Geka Gakkai Zasshi|January 1, 1985
[An in vitro sensitivity assay of anti-cancer agents by measuring the inhibition rate of DNA synthesis (3H-thymidine uptake) of cancer cells--clinical study]Y Nio, T Inamoto, K Ohgaki, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1990
Comparison between crude interleukin-2 and recombinant interleukin-2 in maintaining killing activity of cultured lymphocytesM Nakanishi, N Kan, T Okino, et al.Pageof 6